NHS hospitals are transitioning to the Galeas bladder test, a significant advancement in bladder cancer diagnosis that allows patients to conduct a urine test at home. This non-invasive method replaces the uncomfortable cystoscopy procedure, which involves inserting a camera into the bladder. The Galeas test has demonstrated a 92% accuracy rate in identifying bladder cancer, significantly higher than the 81% accuracy of cystoscopy. As of now, five hospitals have adopted the test, with at least 16 more expected to implement it by year-end. Early data indicates that patients receive results in an average of 16 days, surpassing the NHS's standard of 28 days for cancer diagnosis. The test, developed by experts at the University of Birmingham, is anticipated to not only enhance patient comfort but also increase testing rates, potentially saving lives. NHS England's national medical director praised the initiative as a prime example of how healthcare professionals are innovating to improve cancer diagnosis and treatment.